Saturday, September 08, 2018 12:35:36 AM
Time Price Volume Market
09/07 0.25 2000 OTO
09/07 0.2499 2063 OTO
09/07 0.2499 7737 OTO
09/07 0.2448 2500 OTO
09/07 0.2448 2500 OTO
09/07 0.24 94 OTO
09/07 0.24 10100 OTO
09/07 0.235 15100 OTO
09/07 0.24 10000 OTO
09/07 0.2448 2500 OTO
09/07 0.2447 7500 OTO
09/07 0.2265 1500 OTO
09/07 0.2265 3500 OTO
09/07 0.228 95000 OTO
09/07 0.228 1250 OTO
09/07 0.228 5000 OTO
09/07 0.2425 2500 OTO
09/07 0.2425 2500 OTO
09/07 0.2424 7800 OTO
09/07 0.2424 4300 OTO
09/07 0.2424 1950 OTO
09/07 0.2424 20000 OTO
09/07 0.2424 10000 OTO
09/07 0.2423 1200 OTO
09/07 0.2424 30000 OTO
09/07 0.2252 98750 OTO
09/07 0.23212 1250 OTO
09/07 0.2301 500 OTO
09/07 0.2301 2500 OTO
Recent DSNY News
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 02/27/2024 03:14:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 08:18:37 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 02:16:42 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 11/28/2023 11:01:54 AM
- Form 5 - Annual statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/13/2023 12:08:34 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/13/2023 12:01:54 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/12/2023 11:57:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/12/2023 11:56:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/12/2023 11:49:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/12/2023 11:44:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/12/2023 11:28:44 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/17/2023 10:04:12 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM